- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Cast Presents: Navigating Burdens and Treatment Challenges of IPF
A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic pulmonary fibrosis (IPF).
Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF).
In this podcast, you’ll hear insight from the following individuals:
- Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine, University of Southern California
- Martin Kolb, MD, PhD, professor of medicine, McMaster University
- Steven Nathan, MD, FCCP, medical director of the Advanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, and professor of medicine, University of Virginia
These experts discuss what IPF is, how it impacts patients’ quality of life, barriers to care, and treatments in the pipeline.
Listen above or through one of these podcast services:
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
